{"id":"yf-17d","safety":{"commonSideEffects":[{"rate":"null","effect":"Fever"},{"rate":"null","effect":"Headache"},{"rate":"null","effect":"Fatigue"}]},"_chembl":{"chemblId":"CHEMBL3686119","moleculeType":"Small molecule","molecularWeight":"418.48"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"It works by inducing a mild infection with a weakened form of the yellow fever virus, which stimulates the immune system to produce antibodies and immune cells that can recognize and fight the virus. This provides long-term immunity against yellow fever.","oneSentence":"YF-17D is a live attenuated vaccine.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:41:12.056Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Prevention of yellow fever"}]},"trialDetails":[{"nctId":"NCT05801978","phase":"PHASE4","title":"Durability of Vaccine Responses","status":"RECRUITING","sponsor":"Emory University","startDate":"2023-04-11","conditions":"Vaccine Response","enrollment":66},{"nctId":"NCT04083430","phase":"PHASE4","title":"Cytotoxicity of Yellow Fever Specific CD8 T Cells Following YF-17D Vaccination","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Aarhus","startDate":"2019-10-08","conditions":"Healthy, Cytotoxicity, Yellow Fever Vaccination Reaction","enrollment":60},{"nctId":"NCT05303909","phase":"PHASE2","title":"The Immunostimulatory Effects of Gentamicin","status":"TERMINATED","sponsor":"Singapore General Hospital","startDate":"2022-05-11","conditions":"Healthy Volunteers","enrollment":33},{"nctId":"NCT04267809","phase":"PHASE2","title":"Modulate Cellular Stress in the Immune Cells to Reduce Rate of Symptomatic Viral Infection","status":"COMPLETED","sponsor":"Singapore General Hospital","startDate":"2021-10-22","conditions":"Endoplasmic Reticulum Stress, Viral Infection, Yellow Fever","enrollment":32},{"nctId":"NCT05901454","phase":"NA","title":"Yellow Fever Human Infection Model With YF-17D","status":"UNKNOWN","sponsor":"Leiden University Medical Center","startDate":"2023-02-17","conditions":"Yellow Fever","enrollment":30},{"nctId":"NCT05568953","phase":"PHASE2","title":"An Experimental Medicine Decipher of a Minimum Correlate of Cellular Immunity","status":"UNKNOWN","sponsor":"Singapore General Hospital","startDate":"2022-09-28","conditions":"Infectious Disease, Yellow Fever, Japanese Encephalitis","enrollment":70},{"nctId":"NCT05468606","phase":"EARLY_PHASE1","title":"Coadministration of GA2 Sporozoites With Adjuvants","status":"UNKNOWN","sponsor":"Leiden University Medical Center","startDate":"2023-02-03","conditions":"Malaria,Falciparum","enrollment":45},{"nctId":"NCT03342898","phase":"PHASE3","title":"Immunogenicity and Safety of Tetravalent Dengue Vaccine (TDV) Administered With a Yellow Fever Vaccine in Adults","status":"COMPLETED","sponsor":"Takeda","startDate":"2018-02-28","conditions":"Dengue","enrollment":900},{"nctId":"NCT03776786","phase":"PHASE1","title":"Safety and Tolerability of an Antibody Against Yellow Fever Virus (TY014) in Humans","status":"COMPLETED","sponsor":"Tysana Pte Ltd","startDate":"2018-12-06","conditions":"Treatment of Acute Yellow Fever Virus Infection","enrollment":37}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":156,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"YF-17D","genericName":"YF-17D","companyName":"Takeda","companyId":"takeda","modality":"Biologic","firstApprovalDate":"","aiSummary":"YF-17D is a live attenuated vaccine. Used for Prevention of yellow fever.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":1,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}